Oct 20, 2026 08:33AM
Oct 20, 2026 08:30AM
Sep 2, 2026 08:00AM
Aug 31, 2026 08:32AM
Aug 31, 2026 08:30AM
Aug 12, 2026 04:05PM
Aug 5, 2026 08:30AM Acrivon moves ACR-2316 cancer drug into randomized dose expansion
Aug 5, 2026 08:30AM
Jul 21, 2026 04:30PM
May 21, 2026 07:30AM
May 15, 2026 04:00PM
May 13, 2026 04:10PM
May 13, 2026 04:10PM
Apr 17, 2026 04:00PM Acrivon presents preclinical data on drug combinations at AACR
Apr 17, 2026 04:00PM
Apr 15, 2026 04:05PM
Mar 19, 2026 07:21AM
Mar 17, 2026 05:54PM
Mar 2, 2026 03:39PM
Feb 24, 2026 08:00AM
Feb 23, 2026 08:00AM Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress
Feb 18, 2026 08:00AM
Feb 17, 2026 10:48AM
Jan 23, 2026 08:13AM
Jan 23, 2026 08:11AM
Jan 8, 2026 07:32AM
Jan 8, 2026 07:30AM
Jan 6, 2026 07:30AM Acrivon Therapeutics schedules clinical data webcast for January 8
Jan 6, 2026 07:30AM
Dec 17, 2025 09:34AM
Dec 17, 2025 09:34AM
Dec 17, 2025 07:30AM
Dec 17, 2025 07:30AM
Nov 13, 2025 04:10PM
Oct 22, 2025 04:27PM Acrivon Therapeutics presents preclinical data for ACR-2316 at cancer conference
Oct 22, 2025 04:15PM
Oct 1, 2025 04:30PM
Aug 13, 2025 04:15PM
May 15, 2025 07:26AM
May 14, 2025 04:10PM
Apr 25, 2025 08:00AM
Apr 7, 2025 04:05PM Acrivon Therapeutics (ACRV) Appoints Mansoor Raza Mirza as Chief Medical Officer
Apr 7, 2025 04:05PM
Mar 27, 2025 05:44PM
Mar 19, 2025 08:00AM
Mar 19, 2025 08:00AM
Feb 5, 2025 08:00AM
Feb 5, 2025 08:00AM
Nov 13, 2024 07:00AM Acrivon Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights
Oct 17, 2024 08:00AM

335,223 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All